Recurrent Non-small Cell Lung Cancer Completed Phase 2 Trials for Cediranib (DB04849)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Completed2 IdentifierTitlePurposeDrugs
NCT00410904AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung CancerTreatment
NCT00245063AZD2171 in Treating Patients With Recurrent Small Cell Lung CancerTreatment